Creative Biolabs-Immuno-oncology

Anti-DR6 (clone 6ZD1G) SynExpress E1-Cy3-cF-X Modified CD8+ T cells (CAT#: ITS-1224-CR2306)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DR6 (clone 6ZD1G). We employs the HBV (EF1α-Cy3-c-Fos-XbaI) vector components and the SynExpress system of the Single base pair Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DR6
Clone
6ZD1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
EF1α
Effector Gene
c-Fos
Insertion Sites
XbaI
Gene Modification
Knock-in
Modification Domain
Single base pair
Carrier Type
HBV
Transformation Accuracy
0.9
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving